• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • Cessação tabágica na gravidez. Guia para profissionais de saúde.
    • Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention
    • Factors associated with the time to the first wheezing episode in infants: a cross-sectional study from the International Study of Wheezing in Infants (EISL)
    • Sex differences in reported and objectively measured sleep in COPD
    • [ BROKEN LINK ] A evolução da DPOC no internamento hospitalar entre 2005-2014
    • Report from the 10th General Meeting Global Alliance Against Chronic Respiratory Diseases
    • E-cigarettes: an evidence update – A report commissioned by Public Health England
    • Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms
    • Assessing the effectiveness of High Intensity Interval Training (HIIT) for smoking cessation in women: HIIT to quit study protocol
    • [ BROKEN LINK ] A qualitative study on Canadian youth’s perspectives of peers who smoke: an opportunity for health promotion
    • Distribution of health literacy strengths and weaknesses across socio-demographic groups: a cross-sectional survey using the Health Literacy Questionnaire (HLQ)
    • Risk of exacerbation in chronic obstructive pulmonary disease
    • Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial
    • Self-reported symptoms of chronic cough and breathlessness in working age men in the city of Izhevsk, Russia: associations with cardiovascular disease risk factors and comorbidities
    • [ BROKEN LINK ] Short-term Effects of a Nicotine-free E-cigarette Compared to a Traditional Cigarette in Smokers and Non-smokers
    • Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
    • CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea – A Systematic Review and Meta-analysis
    • The minimal important difference for the St George’s Respiratory Questionnaire in patients with severe COPD
    • Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity
    • [ BROKEN LINK ] A Practitioner’s Guide to Electronic Cigarettes in the Adolescent Population
    • [ BROKEN LINK ] Challenges of inhaler use in the treatment of Asthma and Chronic Obstructive Pulmonary Disease
    • Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
    • Predicting frequent COPD exacerbations using primary care data
    • Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados